When it comes to pharma, then, Cramer recommends investors avoid Teva and opt for rivals Merck (MRK), Johnson & Johnson (JNJ) or GlaxoSmithKline (London Stock Exchange: GSK-GB) instead.
More From CNBC
Sentiment: Strong Sell
Every stock Cramer pumps is at a 52 week high. I think he is a pumper dumper. I like PFE but now I'm worried. I wish they got rid of Cramer.
...but you fail to mentioned the 10 minutes he spent on telling his viewers of the advantages of being a PFE holder. It seems to be that you missed the boat indicating with your derogatory sentiment.
Sentiment: Strong Buy